|This Slide: #14 of 100|
Slide #14. Bayer AG — Merck Consumer Care Business
Merck Consumer Care Business (NYSE:MRK)
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to sell its Merck Consumer Care (MCC) business to Bayer AG (BAYRY) for $14.2 billion. Under the terms of the agreement, Bayer AG will acquire Merck's existing OTC business, including the global trademark and prescription rights for Claritin and Afrin.
Strong Buy (3.59 out of 4)
(ranked higher than approx. 67% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite